Therapy News and Research

RSS

Study opens door to new class of therapies for Ras-dependent cancers

New research from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai identifies a protein that may be an unexplored target to develop new cancer therapies.

9 Sep 2016

New treatment reduces activity of Huntington's disease gene for several months in mice

A single injection of a new treatment has reduced the activity of the gene responsible for Huntington's disease for several months in a trial in mice.

9 Sep 2016

Liquid biopsies may be effective option for detecting mutations in advanced lung cancer patients

For patients with advanced lung cancer, a non-invasive liquid biopsy may be a more effective and suitable alternative to the gold standard tissue biopsy to detect clinically relevant mutations and help guide their course of treatment, suggests a new study published this week in the journal Clinical Cancer Research from researchers at the Abramson Cancer Center at the University of Pennsylvania.

9 Sep 2016

UTHealth receives DOD award to investigate stem cell therapy in adults with TBI

A research team led by Charles S. Cox, Jr., M.D., at The University of Texas Health Science Center at Houston has been awarded $6.8 million from the U.S. Department of Defense to assess the safety and efficacy of using autologous stem cell therapy in adults with emergent traumatic brain injury.

9 Sep 2016

Viral vector-based approaches could improve effectiveness of CFTR gene therapy

Cystic fibrosis (CF) is characterized by accumulation of thick mucus in the lungs and is associated with a high incidence of bacterial infection. Mutations in the gene encoding CF transmembrane conductance regulator (CFTR) underlie the disease.

9 Sep 2016

Researchers identify higher risk of early chemotherapy-related death in older patients with DLBCL

Although diffuse large B-cell lymphoma (DLBCL) is a curable disease in most patients aged 65 years or older, these patients are also at higher risk of chemotherapy-related death within the first 30 days of treatment.

9 Sep 2016

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

In research published online today in Science, a team of scientists describe a new therapeutic strategy to target a hidden Achilles' heel shared by all known types of Ebola virus.

8 Sep 2016

Researchers reveal potential therapeutic treatment for alphavirus infections

Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment for the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus (RRV) and Chikungunya Virus (CHIKV).

8 Sep 2016

Animal-assisted therapy can help students combat homesickness, study shows

The expression dog is man's best friend might have more weight in the case of first-year university students suffering from homesickness, according to a new UBC study.

8 Sep 2016

AAGBI releases new standards of monitoring during anaesthesia for better patient safety

The Association of Anaesthetists of Great Britain and Ireland has this month published new Standards in patient monitoring (Recommendations for standards of monitoring during anaesthesia and recovering 2016), and calls for all hospitals to work towards using capnography for all anaesthetist-led sedation to improve patient safety.

8 Sep 2016

New study reveals benefits of home non-invasive ventilation in improving lives of COPD patients

Today ResMed welcomed positive results from the independent Home Oxygen Therapy- Home Mechanical Ventilation (HOT-HMV) study regarding the benefits of home non-invasive ventilation (NIV).

From ResMed Corp 8 Sep 2016

Experimental drug shows promise for stopping melanoma and other forms of cancer

An experimental cancer drug works differently than intended and shows significant promise for stopping melanoma and possibly other forms of cancer, research from the University of Virginia School of Medicine suggests.

7 Sep 2016

Study shows adequate sleep may accelerate antidepressant treatment response

Medication is an important part of treatment for many patients with major depressive disorder, but the transition to antidepressants isn't always smooth.

7 Sep 2016

Researchers unlock genetic code that disrupts response to breast cancer therapy

Scientists may have unlocked the genetic code that determines why many patients with estrogen receptor-positive breast cancer fail to respond to the widely used drug tamoxifen.

7 Sep 2016

New computer program can predict underlying genomics of ER+ breast cancer

The number of tubules in tumors may predict which women with estrogen receptor positive (ER+) breast cancer will benefit from hormone therapy alone and which require chemotherapy, researchers at Case Western Reserve University have found.

7 Sep 2016

Groundbreaking research on effects of NIR light could lead to effective treatment for PTSD

After years of studying the effects of near-infrared light on veterans with post-traumatic stress disorder or traumatic brain injuries, a team led by a University of Texas at Arlington bioengineer has published groundbreaking research in Nature's Scientific Reports that could result in an effective, long-term treatment for brain disorders.

7 Sep 2016

Cedars-Sinai researchers develop new way to identify patients at risk for aggressive prostate cancer

Scientists at Cedars-Sinai have developed a new way to identify which prostate cancer patients are likely to develop aggressive types of the disease even if their tumors at first appear to be lower risk.

7 Sep 2016

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Global health experts are today are calling for the removal of restrictions preventing people who use drugs from accessing new hepatitis C cures. So long as these restrictions exist, the goal of disease elimination will remain out of reach, they say.

7 Sep 2016

Researchers isolate cord blood factor that helps fight harmful inflammation

A factor found in umbilical cord blood could become the basis for developing a new therapy to fight harmful inflammation, University of Utah School of Medicine researchers report.

7 Sep 2016

Study shows link between steroid use and poor outcomes in Lyme disease-associated facial paralysis

Researchers from Massachusetts Eye and Ear/Harvard Medical School have found that patients who were prescribed corticosteroids as part of treatment for Lyme disease-associated facial paralysis had worse long-term outcomes of regaining facial function than those who were prescribed antibiotic therapy alone.

7 Sep 2016

Therapy News and Research

Study opens door to new class of therapies for Ras-dependent cancers

New treatment reduces activity of Huntington's disease gene for several months in mice

Liquid biopsies may be effective option for detecting mutations in advanced lung cancer patients

UTHealth receives DOD award to investigate stem cell therapy in adults with TBI

Viral vector-based approaches could improve effectiveness of CFTR gene therapy

Researchers identify higher risk of early chemotherapy-related death in older patients with DLBCL

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

Researchers reveal potential therapeutic treatment for alphavirus infections

Animal-assisted therapy can help students combat homesickness, study shows

AAGBI releases new standards of monitoring during anaesthesia for better patient safety

New study reveals benefits of home non-invasive ventilation in improving lives of COPD patients

Experimental drug shows promise for stopping melanoma and other forms of cancer

Study shows adequate sleep may accelerate antidepressant treatment response

Researchers unlock genetic code that disrupts response to breast cancer therapy

New computer program can predict underlying genomics of ER+ breast cancer

Groundbreaking research on effects of NIR light could lead to effective treatment for PTSD

Cedars-Sinai researchers develop new way to identify patients at risk for aggressive prostate cancer

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Researchers isolate cord blood factor that helps fight harmful inflammation

Study shows link between steroid use and poor outcomes in Lyme disease-associated facial paralysis

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News